Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Journal of Bioactive and Compatible Polymers
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Caliceti, P.
Right arrow Articles by Veronese, F. M.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Preservation of Thrombolytic Activity of Urokinase Modified with Monomethoxypoly(ethylene glycol

Paolo Caliceti

Department of Pharmaceutical Sciences Centro di Studio di Chimica del Farmaco e dei Prodotti Biologicamente Attivi del CNR University of Padova Via F. Marzolo, 5-35131 Padova, Italy

Margherita Morpurgo

Department of Pharmaceutical Sciences Centro di Studio di Chimica del Farmaco e dei Prodotti Biologicamente Attivi del CNR University of Padova Via F. Marzolo, 5-35131 Padova, Italy

Oddone Schiavon

Department of Pharmaceutical Sciences Centro di Studio di Chimica del Farmaco e dei Prodotti Biologicamente Attivi del CNR University of Padova Via F. Marzolo, 5-35131 Padova, Italy

Cristina Monfardini

Department of Pharmaceutical Sciences Centro di Studio di Chimica del Farmaco e dei Prodotti Biologicamente Attivi del CNR University of Padova Via F. Marzolo, 5-35131 Padova, Italy

Francesco M. Veronese

Department of Pharmaceutical Sciences Centro di Studio di Chimica del Farmaco e dei Prodotti Biologicamente Attivi del CNR University of Padova Via F. Marzolo, 5-35131 Padova, Italy

A method is described to modify urokinase by covalent binding of monomethoxypoly(ethylene glycol) (mPEG) without impairing its catalytic ac tivity towards high molecular weight substrates. The urokinase active site is protected by an inhibitor, benzamidine, bound to Sepharose during the mPEG modification in order to avoid binding mPEG chains to the active site or to the surrounding area. The mPEG modified urokinase had increased activity towards small molecular weight substrates (acetyl-Gly-methyl ester) as com pared to the unmodified enzyme, while the activity towards the high molecular weight plasminogen and the insoluble substrate fibrin clot was preserved. This did not occur when the enzyme was modified in the absence of active site pro tection. The polymer modification increased the enzyme's thermostability and the stability in plasma in vitro and prolonged in vivo retention after in travenous injection in rats.

Journal of Bioactive and Compatible Polymers, Vol. 9, No. 3, 252-266 (1994)
DOI: 10.1177/088391159400900302
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?